+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Impact on Publicly Traded Bio/Pharma Companies - Coronavirus Disease (COVID-19) 2019 Impact Report

  • ID: 5117452
  • Report
  • June 2020
  • Region: Global
  • 34 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novo Nordisk AS
  • MORE
Summary

The Coronavirus (COVID-19) company impact report analyses how the pandemic has impact the top 20 Mega Cap Bio/Pharma Companies revenue, future revenue, and market capitalization.

Scope
  • This report gives an important expert analysis on how COVID-19 has affected, and will continue to affect, the top 20 Mega Cap Bio/Pharma Companies. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.
Reasons to Buy
  • An overview of how the top 20 Mega Cap Bio/Pharma Companies have been affected, and will continue to be affected, by the COVID-19 pandemic.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novo Nordisk AS
  • MORE
1. Market Cap Change for Bio/Pharma Companies in Q1 2020
  • Market Cap for Bio/Pharma Companies With and Without a COVID-19 Drug over Q1 2020
  • Q1 2020 Change in Market Cap by Company Market Cap Size
2. Market Cap for Top 20 Bio/Pharma Companies: Q1 2020 vs. 2019
  • Market Cap Change for Top 20 Bio/Pharma: Q1 2020 vs. 2019
  • Market Cap Change Q1 2020: Bayer AG
  • Market Cap Change Q1 2020: Gilead Sciences
  • Market Cap Change Q1 2020: Regeneron Pharmaceuticals
  • Q1 2020 Market Cap Change for Top 20 Bio/Pharma: With and Without a COVID-19 Drug
  • Market Cap Growth: Q1 2020 vs. 2019 Biggest Movers
  • Market Cap Change Q1 2020: AbbVie Inc
3. Drug Sales for Top 20 Bio/Pharma Companies vs. Market Cap
  • Global Total Drug Sales for Q1 2020 vs. Market Cap
4. Drug Sales for Top 20 Bio/Pharma Companies Q1 2020 vs. Q4 2019
  • Global Total Drug Sales Q1 2020 vs. Q4 2019
5. Drug Sales for Top 20 Bio/Pharma Companies vs. Archived Forecasts
  • Q1 2020 Actual Sales vs. Archived Global Analyst Consensus Sales Forecast for Top-Selling Drugs
  • Total Q1 2020 Actual Sales vs. Total Archived Global Analyst Consensus Sales Forecast
  • Key Findings
  • Appendix
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Merck & Co Inc
  • Pfizer Inc
  • Bristol-Myers Squibb Co
  • Amgen Inc
  • AbbVie Inc
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Sanofi
  • GlaxoSmithKline Plc
  • Novo Nordisk AS
  • CSL Ltd
  • Gilead Sciences Inc
  • Bayer AG
  • Allergan Plc
  • Vertex Pharmaceuticals Inc
  • Biogen Inc
  • Regeneron Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll